id: NEW:blood_donation_system_participation_to_NEW:bartonella_quintana_transmission_risk
name: Blood Donation System Participation â†’ Bartonella quintana Transmission Risk
from_node:
  node_id: NEW:blood_donation_system_participation
  node_name: Blood Donation System Participation
to_node:
  node_id: NEW:bartonella_quintana_transmission_risk
  node_name: Bartonella quintana Transmission Risk
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Blood donors from general population may have subclinical or undetected B. quintana infections'
- 'Step 2: Review found 12/20 blood donor subpopulations had positive seroprevalence rates'
- 'Step 3: Asymptomatic bacteremia can persist in blood products'
- 'Step 4: Transfusion of contaminated blood products represents potential transmission route'
- 'Step 5: Healthcare system exposure factors were not adequately identified in existing literature'
evidence:
  quality_rating: A
  n_studies: 45
  primary_citation: Ba-Hoang-Anh Mai 2022. "Seroprevalence of ." https://doi.org/10.4103/jgid.jgid_220_21
  supporting_citations:
  - 12 out of 20 blood donor subpopulations showed positive seroprevalence
  - Factors of exposure in blood donor groups were not identified in reviewed literature
  - Additional citations require full-text access for specific study details
  doi: 10.4103/jgid.jgid_220_21
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The systematic review identified that 12 out of 20 blood donor subpopulations showed positive
  seroprevalence for B. quintana, yet factors of exposure in this group were not identified in the reviewed
  literature. This represents a significant gap in understanding potential healthcare-associated transmission
  routes and blood supply safety considerations.
spatial_variation:
  varies_by_geography: true
  variation_notes: Variation in blood donor seroprevalence across different countries suggests geographic
    and screening protocol differences
structural_competency:
  equity_implications: 'This finding highlights a healthcare system infrastructure gap: blood screening
    protocols may not adequately detect or screen for B. quintana, potentially creating transmission risk
    through the healthcare system itself. This represents a structural vulnerability in blood safety systems
    that requires policy attention for screening protocols and epidemiological surveillance.'
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.519072'
  extraction_confidence: low
  prompt_version: 2.1-canonical-validated
